🔴 Marker Therapeutics is trading 5% down in after-hours trading

Marker Therapeutics is trading at $1.14, down 5.00%, in after-hours trading; the available information does not establish a reason for the decline.

• It closed at $1.20 on October 19, after gains of 13.04% on October 16 and 15.38% on October 19.
• On October 19, the company announced a $2.6 million FDA grant to support a Phase 1 MT-601 pancreatic cancer study; the news does not explain the after-hours decline.
• Available market context is mixed and does not establish a broader-market explanation for the drop.